SCHEMBL9905335

SCHEMBL9905335

O=C(N=C(NCc1cc(F)c(F)c(F)c1)Nc1cc(C(F)(F)F)n[nH]1)c1ccc(Cl)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 3/20 0.35
TP53 P04637 1/20 0.35
ADORA2A P29274 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
RHOC P08134 1/20 0.34
RHOA P61586 1/20 0.34
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
GSK3B P49841 1/20 0.34
FABP4 P15090 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
EPHX2 P34913 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9905331 1.00 HPGD (0.35) HPGDALDH1A1MAPTTP53ADORA2A
SCHEMBL9905169 0.91 NTRK1 (0.36) HPGDALDH1A1MAPTTP53ADORA2A
SCHEMBL9905171 0.91 NTRK1 (0.36) HPGDALDH1A1MAPTTP53ADORA2A
SCHEMBL17088575 0.87 ROCK2 (0.37) HPGDMAPTTP53ROCK2ROCK1
SCHEMBL9921096 0.85 MEN1 (0.48) HPGDALDH1A1MAPTTDP1HDAC3
SCHEMBL9920875 0.82 RAB9A (0.35) HPGDMAPTRHOCRHOAHDAC6
SCHEMBL17088583 0.82 EPHX2 (0.46) ROCK2ROCK1PPARGEPHX2HDAC3
SCHEMBL9920877 0.79 MEN1 (0.36) ALDH1A1MAPTHDAC6RAB9ACYP1A2
SCHEMBL17509141 0.79 MEN1 (0.36) ALDH1A1MAPTHDAC6RAB9ACYP1A2
SCHEMBL9921075 0.79 MAPT (0.34) MAPTTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648511-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF Lycera Corporation (US) 2013-10-16 EP disclosed
WO-2012078874-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed